Amydis, Inc

Amydis is leading the way for early detection of diseases through the eye that is accessible, affordable and non-invasive. The company is developing proprietary ocular tracers that enable identification of molecular biomarkers for diseases of the eye, heart and brain. Amydis is creating a data warehouse for multi-omics that includes unique molecular biomarkers of the eye to empower AI-enabled health insights. The Companys digital health solutions leverage the eye as the window to the body to accelerate diagnoses, enable precision treatment and improve patient outcomes

Diagnostics,amyloids,neurodegeneration,ophthalmology,als,parkinson's disease,digital biomarker,surrogate biomarker,molecular diagnostics,alzheimer's disease,cerebral amyloid angiopathy,retina,imaging,and eye

Amydis, inc operates in the Biotechnology research industry.

Amydis, inc's revenue is 11m - 100m

Amydis, inc has 11 - 50 employees.